Processing of beta-dystroglycan by matrix metalloproteinase disrupts the link between the extracellular matrix and cell membrane via the dystroglycan complex
- PMID: 11468274
- DOI: 10.1093/hmg/10.15.1563
Processing of beta-dystroglycan by matrix metalloproteinase disrupts the link between the extracellular matrix and cell membrane via the dystroglycan complex
Abstract
The dystroglycan complex is a membrane-spanning complex composed of two subunits, alpha- and beta-dystroglycan. alpha-dystroglycan is a cell surface peripheral membrane protein which binds to the extracellular matrix (ECM), whereas beta-dystroglycan is an integral membrane protein which anchors alpha-dystroglycan to the cell membrane. The dystroglycan complex provides a tight link between the ECM and cell membrane. Dysfunction of the dystroglycan complex has commonly been implicated in the molecular pathogenesis of severe forms of hereditary neuromuscular diseases, including Duchenne muscular dystrophy, Fukuyama-type congenital muscular dystrophy and sarcoglycanopathy (LGMD2C, -D, -E and -F). To begin to clarify the pathway by which the dysfunction of the dystroglycan complex could lead to muscle cell degeneration, we investigated the proteolytic processing of the dystroglycan complex in this study. We demonstrate that (i) a 30 kDa fragment of beta-dystroglycan is expressed in peripheral nerve, kidney, lung and smooth muscle, but not skeletal muscle, cardiac muscle or brain, and (ii) this fragment is the product of proteolytic processing of the extracellular domain of beta-dystroglycan by the membrane-associated matrix metalloproteinase (MMP) activity. Importantly, furthermore, we demonstrate that this processing disintegrates the dystroglycan complex. Our results indicate that the processing of beta-dystroglycan by MMP causes the disruption of the link between the ECM and cell membrane via the dystroglycan complex, which could have profound effects on cell viability. Based on these and previously reported findings, we propose a hypothesis that this processing may play a crucial role in the molecular pathogenesis of sarcoglycanopathy.
Similar articles
-
Disruption of dystroglycan axis by beta-dystroglycan processing in cardiomyopathic hamster muscle.Neuromuscul Disord. 2003 Dec;13(10):796-803. doi: 10.1016/s0960-8966(03)00139-1. Neuromuscul Disord. 2003. PMID: 14678802
-
Proteolysis of beta-dystroglycan in muscular diseases.Neuromuscul Disord. 2005 May;15(5):336-41. doi: 10.1016/j.nmd.2005.01.007. Neuromuscul Disord. 2005. PMID: 15833425
-
Dystroglycan distribution in adult mouse brain: a light and electron microscopy study.Neuroscience. 2001;104(2):311-24. doi: 10.1016/s0306-4522(01)00092-6. Neuroscience. 2001. PMID: 11377836
-
Defective glycosylation in muscular dystrophy.Lancet. 2002 Nov 2;360(9343):1419-21. doi: 10.1016/S0140-6736(02)11397-3. Lancet. 2002. PMID: 12424008 Review.
-
Dystroglycan: an extracellular matrix receptor linked to the cytoskeleton.Curr Opin Cell Biol. 1996 Oct;8(5):625-31. doi: 10.1016/s0955-0674(96)80103-7. Curr Opin Cell Biol. 1996. PMID: 8939660 Review.
Cited by
-
Tissue inhibitor of metalloproteinase-2(TIMP-2)-deficient mice display motor deficits.J Neurobiol. 2006 Jan;66(1):82-94. doi: 10.1002/neu.20205. J Neurobiol. 2006. PMID: 16216006 Free PMC article.
-
The rapid decrease in astrocyte-associated dystroglycan expression by focal cerebral ischemia is protease-dependent.J Cereb Blood Flow Metab. 2008 Apr;28(4):812-23. doi: 10.1038/sj.jcbfm.9600585. Epub 2007 Nov 21. J Cereb Blood Flow Metab. 2008. PMID: 18030304 Free PMC article.
-
Regulation of pulmonary endothelial barrier function by kinases.Am J Physiol Lung Cell Mol Physiol. 2016 Nov 1;311(5):L832-L845. doi: 10.1152/ajplung.00233.2016. Epub 2016 Sep 23. Am J Physiol Lung Cell Mol Physiol. 2016. PMID: 27663990 Free PMC article. Review.
-
An ischemic beta-dystroglycan (betaDG) degradation product: correlation with irreversible injury in adult rabbit cardiomyocytes.Mol Cell Biochem. 2003 Jan;242(1-2):71-9. Mol Cell Biochem. 2003. PMID: 12619868
-
VHL-dependent regulation of a β-dystroglycan glycoform and glycogene expression in renal cancer.Int J Oncol. 2013 Nov;43(5):1368-76. doi: 10.3892/ijo.2013.2066. Epub 2013 Aug 21. Int J Oncol. 2013. PMID: 23970118 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous